These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 29234213)
1. Progress in Nanomedicine: Approved and Investigational Nanodrugs. Ventola CL P T; 2017 Dec; 42(12):742-755. PubMed ID: 29234213 [TBL] [Abstract][Full Text] [Related]
2. Patented and Approval Scenario of Nanopharmaceuticals with Relevancy to Biomedical Application, Manufacturing Procedure and Safety Aspects. Agarwal V; Bajpai M; Sharma A Recent Pat Drug Deliv Formul; 2018; 12(1):40-52. PubMed ID: 29303083 [TBL] [Abstract][Full Text] [Related]
3. Nanodrugs used in cancer therapy. Kopeckova K; Eckschlager T; Sirc J; Hobzova R; Plch J; Hrabeta J; Michalek J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):122-131. PubMed ID: 30967685 [TBL] [Abstract][Full Text] [Related]
4. Nanopharmaceuticals (part 2): products in the pipeline. Weissig V; Guzman-Villanueva D Int J Nanomedicine; 2015; 10():1245-57. PubMed ID: 25709446 [TBL] [Abstract][Full Text] [Related]
5. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes. Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844 [TBL] [Abstract][Full Text] [Related]
6. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials. Havel HA AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380 [TBL] [Abstract][Full Text] [Related]
7. Nanomedicine and epigenome. Possible health risks. Smolkova B; Dusinska M; Gabelova A Food Chem Toxicol; 2017 Nov; 109(Pt 1):780-796. PubMed ID: 28705729 [TBL] [Abstract][Full Text] [Related]
8. Nanomedicine: de novo design of nanodrugs. Yang Z; Kang SG; Zhou R Nanoscale; 2014 Jan; 6(2):663-77. PubMed ID: 24305636 [TBL] [Abstract][Full Text] [Related]
9. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic. Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391 [TBL] [Abstract][Full Text] [Related]
10. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Caster JM; Patel AN; Zhang T; Wang A Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27312983 [TBL] [Abstract][Full Text] [Related]